David Kim, PharmD
David Kim, PharmD
Dr. Kim is a graduate of MCPHS University in Boston, MA. He is currently serving his country as a Pharmacy Specialist in the United States Army Reserve. He is a certified immunizer and holds other APhA certifications such as Medication Therapy Management and Diabetes Care. The views expressed in his publications do not reflect the views of the United States Army, Department of Defense, or the United States Government.
Articles
Apr 26, 2018 @06:06 AM
Solanezumab did not significantly affect cognitive decline compared with the placebo in subjects with mild Alzheimer's, but there are still takeaways.

Apr 13, 2018 @07:56 PM
Pharmacists often encounter patients with Heparin-induced Thrombocytopenia (HIT) in health care settings. Here are some useful information in regards to HIT.

Feb 16, 2018 @02:00 PM
Tissue Plasminogen Activator (tPA) is administered in patients with Acute Ischemic Stroke. Becuase tPA administration is time sensitive, caution is required.

Dec 21, 2017 @04:25 AM
HMG-CoA reductase inhibitors are a class of lipid-lowering medications. Here is a look at guidelines and studies for health care professionals.

Nov 16, 2017 @02:29 AM
What role does this medication play in diabetes therapy, and what are its clinical benefits, compared with competitors?